Oppenheimer Cuts Price Target on Honeywell (HON) to $122 Ahead of 3Q Release
- Wall Street gains, helped by oil, economic data
- Twitter (TWTR) 'Takeover Money' Moves On as 'Trump Money' Moves In
- Buy Any Seasonal Market Weakness Ahead of Year End Rally - Oppenheimer (SPY)
- Unusual 11 Mid-Day Movers 12/5: (NVCN) (BCEI) (MEMP) Higher; (GTXI) (CERC) (HDSN) Lower
- Oil hits 16-month high in buying rush after OPEC agreement
Get daily under-the-radar research with StreetInsider.com's Stealth Growth Insider Get your 2-Wk Free Trial here.
Oppenheimer maintained an Outperform rating on Honeywell International (NYSE: HON), and cut the price target to $122.00 (from $128.00), ahead of the company's 3Q earnings release. HON is expected to release results on 10/21/2016.
Analyst Christopher Glynn commented, "HON lowered 3Q organic to -3%, vs. prior +0-1%, ~$300M miss ($9.8B guide vs. prior $10.0-10.2B). New 3Q preliminary EPS of $1.60 compares to prior guidance for $1.67-1.72. Guidance includes $75M additional Aero OEM milestone payments in 3Q (top-line reduction that falls through; now $250M incremental for year vs. prior ~ $200M vs. 2015), representing about $0.07 EPS offset to $0.21 of expected 3Q gains (including $0.14 gain on sale, $0.07 tax gain related to change to pending rules on stock compensation accounting). Incremental restructuring deployment accounts for the balance of $0.18 reinvestment of benefits, netting to $0.03 net benefit—this is how we reconcile $0.10 3Q lower EPS expectation ($0.13 operational shortfall; $0.03 net benefits)."
Shares of Honeywell International closed at $106.94 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- UPDATE: Goldman Sachs Downgrades Marvell (MRVL) to Sell
- Instinet Raises Price Target on Noble Energy (NBL) to $44; Reiterates Buy
- Jefferies Raises Price Target on Zumiez, Inc. (ZUMZ) to $23 Following 3Q
Create E-mail Alert Related CategoriesAnalyst Comments, Analyst EPS Change, Analyst PT Change
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!